Fundraising FoxRoivant
2 known investors
Find your way into Roivant
Roivant develops pharmaceutical medicines and medical technologies through a subsidiary model called "Vants," focused on accelerating the development and commercialization of treatments for dermatology and other therapeutic areas. The company operates as a biopharmaceutical holding with multiple focused companies advancing drug candidates through clinical trials and commercial launch.
Founders & leadership
VR
Vivek Ramaswamy
IC
Iván Cornella-TaracidoVice President of Translational Chemical Biology
Investors · 2
Commonweal Ventureslisted by Commonweal VenturesNew York · $500K – $2.5M
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Roivant do?
- Roivant develops pharmaceutical medicines and medical technologies through a subsidiary model called "Vants," focused on accelerating the development and commercialization of treatments for dermatology and other therapeutic areas. The company operates as a biopharmaceutical holding with multiple focused companies advancing drug candidates through clinical trials and commercial launch.
- Who founded Roivant?
- Roivant was founded by Vivek Ramaswamy.
- Who are Roivant's investors?
- Roivant's investors include Commonweal Ventures, SoftBank Vision Fund.